GMP Rule’s Returned Product Testing Provision Is Overly Restrictive – NBTY
This article was originally published in The Tan Sheet
Executive Summary
FDA's proposal to require testing of any returned dietary supplement products prior to resale is overly restrictive and without precedence in other product areas, NBTY asserts
You may also be interested in...
Dietary Supplement “Flexible” Testing Requirements Proposed In GMPs
FDA's proposed good manufacturing practices for dietary supplements would require final product testing for adherence to identity, purity, quality, strength and composition specifications unless a scientifically valid analytical method does not exist
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands